2022 Clinical Nuclear Medicine - A CME Teaching Activity

This CME Teaching Activity is designed to provide a practical yet in-depth review of nuclear medicine with concentration on the latest trends, protocols and advances in clinical diagnosis and patient management. Faculty discuss techniques, tips, common artifacts and pitfalls through didactic lectures and case-based presentations.

This activity should benefit nuclear medicine physicians, and radiologists. It should also benefit physicians who supervise and interpret nuclear medicine procedures. The course should also prove valuable for physicians who order these studies.

Educational Symposia

Physicians: Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Educational Symposia designates this enduring material for a maximum of 8.75 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All activity participants are required to complete the credit application in order to be awarded credit. Course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.

AMA PRA Category 1 Credit(s)^TM for these programs may be claimed until October 14, 2025.

This program is planned and organized by Educational Symposia, a leader in accredited continuing education since 1975.

This activity was planned and produced in accordance with the ACCME Essential Areas and Elements.

At the completion of this CME teaching activity, you should be able to:

• Apply state-of-the-art protocols to assess a lung and gastrointestinal disorders.
• Discuss current and future directions of nuclear medicine.
• Discuss the expanding role of SPECT/CT.
• Describe the role of nuclear medicine when used to evaluate thyroid, cardiac and renal disorders.
• Explain the expanding role of nuclear medicine in the detection and management of thyroid and prostate bone cancers.

No special educational preparation is required for this CME activity.